276 related articles for article (PubMed ID: 17935275)
1. Advancements in Oncoproteomics Technologies: Treading toward Translation into Clinical Practice.
Punetha A; Kotiya D
Proteomes; 2023 Jan; 11(1):. PubMed ID: 36648960
[TBL] [Abstract][Full Text] [Related]
2. Precision Oncology: The Road Ahead.
Senft D; Leiserson MDM; Ruppin E; Ronai ZA
Trends Mol Med; 2017 Oct; 23(10):874-898. PubMed ID: 28887051
[TBL] [Abstract][Full Text] [Related]
3. dbDEPC 2.0: updated database of differentially expressed proteins in human cancers.
He Y; Zhang M; Ju Y; Yu Z; Lv D; Sun H; Yuan W; He F; Zhang J; Li H; Li J; Wang-Sattler R; Li Y; Zhang G; Xie L
Nucleic Acids Res; 2012 Jan; 40(Database issue):D964-71. PubMed ID: 22096234
[TBL] [Abstract][Full Text] [Related]
4. Identifying pathological biomarkers: histochemistry still ranks high in the omics era.
Pellicciari C; Malatesta M
Eur J Histochem; 2011 Dec; 55(4):e42. PubMed ID: 22297448
[TBL] [Abstract][Full Text] [Related]
5. Proteomics and Its Current Application in Biomedical Area: Concise Review.
Gobena S; Admassu B; Kinde MZ; Gessese AT
ScientificWorldJournal; 2024; 2024():4454744. PubMed ID: 38404932
[TBL] [Abstract][Full Text] [Related]
6. Extracellular Vesicle Membrane Protein Profiling and Targeted Mass Spectrometry Unveil CD59 and Tetraspanin 9 as Novel Plasma Biomarkers for Detection of Colorectal Cancer.
Dash S; Wu CC; Wu CC; Chiang SF; Lu YT; Yeh CY; You JF; Chu LJ; Yeh TS; Yu JS
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612172
[TBL] [Abstract][Full Text] [Related]
7. Proteomics: Concepts and applications in human medicine.
Al-Amrani S; Al-Jabri Z; Al-Zaabi A; Alshekaili J; Al-Khabori M
World J Biol Chem; 2021 Sep; 12(5):57-69. PubMed ID: 34630910
[TBL] [Abstract][Full Text] [Related]
8. Application of oncoproteomics to aberrant signalling networks in changing the treatment paradigm in acute lymphoblastic leukaemia.
López Villar E; Wang X; Madero L; Cho WC
J Cell Mol Med; 2015 Jan; 19(1):46-52. PubMed ID: 25537633
[TBL] [Abstract][Full Text] [Related]
9. Identification of patients with nasopharyngeal carcinoma by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Zhu XD; Su F; Liang ZG; Li L; Qu S; Liang X; Wang Q; Liang SX; Chen L
Int J Clin Oncol; 2014 Aug; 19(4):579-85. PubMed ID: 24072388
[TBL] [Abstract][Full Text] [Related]
10. Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.
De Bock M; de Seny D; Meuwis MA; Chapelle JP; Louis E; Malaise M; Merville MP; Fillet M
J Biomed Biotechnol; 2010; 2010():906082. PubMed ID: 20029632
[TBL] [Abstract][Full Text] [Related]
11. Innovations, challenges and future prospects of oncoproteomics.
Jain KK
Mol Oncol; 2008 Aug; 2(2):153-60. PubMed ID: 19383334
[TBL] [Abstract][Full Text] [Related]
12. Role of oncoproteomics in the personalized management of cancer.
Jain KK
Expert Rev Proteomics; 2004 Jun; 1(1):49-55. PubMed ID: 15966798
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in oncoproteomics.
Jain KK
Curr Opin Mol Ther; 2002 Jun; 4(3):203-9. PubMed ID: 12139304
[TBL] [Abstract][Full Text] [Related]
14. Oncoproteomics: current trends and future perspectives.
Cho WC; Cheng CH
Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924
[TBL] [Abstract][Full Text] [Related]
15. Oncoproteomics.
Joshi S; Tiwari AK; Mondal B; Sharma A
Clin Chim Acta; 2011 Jan; 412(3-4):217-26. PubMed ID: 20955692
[TBL] [Abstract][Full Text] [Related]
16. Integrative oncoproteomics strategies for anticancer drug discovery.
Liu R; Wang K; Yuan K; Wei Y; Huang C
Expert Rev Proteomics; 2010 Jun; 7(3):411-29. PubMed ID: 20536311
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in clinical oncoproteomics.
Jain KK
J BUON; 2007 Sep; 12 Suppl 1():S31-8. PubMed ID: 17935275
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
